LXRX - Lexicon Pharmaceuticals Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2021 Earnings Conference Call May 06, 2021, 05:00 PET Company Participants Chas Schultz - Executive Director of Corporate Communications & Patient Advocacy Lonnel Coats - President and Chief Executive Officer and Director Jeff Wade - Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Joseph Stringer - Needham & Company Presentation Operator Good morning, good afternoon and good evening. My name is Donna and I will be your conference operator today. At this time I would like to welcome everyone to Lexicon Pharmaceuticals Incorporated First Quarter's 2021 Earnings Call. [Operator Instructions] I would now like to hand the conference over to your first speaker for today, Chas Schultz, Executive Director of Corporate Communications and Investor Relations. Thank you. Please go ahead, sir. Chas Schultz Thank you, Donna. Good afternoon and welcome to the Lexicon Pharmaceuticals first

For further details see:

Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call Transcript